2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
13
Neoplasms
12
Brain Neoplasms
6
Prostatic Neoplasms
5
Neoplasm Metastasis
4
Lung Neoplasms
4
Sarcoma
3
Multiple Myeloma
3
Melanoma
3
Glioblastoma
3
Gastrointestinal Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Synovial
2
Rectal Neoplasms
2
Pain
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neuroendocrine Tumors
2
Nasopharyngeal Carcinoma
2
Mesothelioma
2
Liposarcoma
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Glioma
2
Fatigue
2
Colorectal Neoplasms
2
Interventions
Ifosfamide
5
Filgrastim
5
Doxorubicin
5
Gemcitabine
4
Docetaxel
4
Radiotherapy
3
Proton Therapy
3
Carboplatin
3
regorafenib
2
ivosidenib
2
enasidenib
2
belinostat
2
Sunitinib
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Immune Checkpoint Inhibitors
2
HhAntag691
2
Fluorouracil
2
Etoposide
2
Epirubicin
2
Cyclophosphamide
2
Cisplatin
2
Chemotherapy, Adjuvant
2
Celecoxib
2
Bevacizumab
2
venetoclax
1
toripalimab
1
temsirolimus
1
tazemetostat
1
tanespimycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chondrosarcoma
×
Quality of Life
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled